Healius Ltd (HLS)

Sydney
3.730
+0.070(+1.91%)
  • Volume:
    4,014,656
  • Bid/Ask:
    3.720/3.730
  • Day's Range:
    3.675 - 3.800

HLS Overview

Prev. Close
3.66
Day's Range
3.675-3.8
Revenue
2.29B
Open
3.79
52 wk Range
3.585-5.54
EPS
0.38
Volume
4,014,656
Market Cap
2.12B
Dividend (Yield)
0.1675
(4.49%)
Average Volume (3m)
2,912,227
P/E Ratio
9.88
Beta
1.26
1-Year Change
-17.11%
Shares Outstanding
569,206,907
Next Earnings Date
18 Aug 2022
What is your sentiment on Primary Health Care?
or
Market is currently closed. Voting is open during market hours.

Healius Ltd Analysis

Healius Ltd Company Profile

Healius Ltd Company Profile

Employees
11000
Market
Australia

Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging, and Day Hospitals. The Pathology segment is a provider of pathology services. The Imaging segment is a provider of imaging and scanning services from standalone imaging sites, hospitals, and medical centers. The Day Hospitals segment is an operator of day hospitals. The Company has a network of pathology laboratories, diagnostic imaging centers, day hospitals, and In-Vitro Fertilization (IVF) clinics. It provides specialty diagnostic services to consumers and their referring practitioners, as well as supporting independent healthcare professionals in the delivery of care in its centers, day hospitals and fertility clinics. It also offers diagnostics, veterinary pathology services to veterinarians. The Company’s brands include QML Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, and Genomic Diagnostic.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsSellNeutralStrong BuyStrong SellStrong Sell
SummaryNeutralBuyStrong BuyStrong SellStrong Sell
  • 2500 shares
    6